Everolimus
5 mg/1 · Tablet
By Novugen Pharma (USA) LLC.
Tablet · 5 mg
- NDC
- 82293-031
- Route
- Oral
- Therapeutic class
- Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor , Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant , mTOR Inhibitors [MoA]
- Marketing category
- ANDA
Package sizes
- 1 POUCH in 1 CARTON (82293-031-31) / 3 BLISTER PACK in 1 POUCH / 10 TABLET in 1 BLISTER PACK (82293-031-30)NDC 82293-031-31Available to Order
- 4 BLISTER PACK in 1 CARTON (82293-031-21) / 7 TABLET in 1 BLISTER PACK (82293-031-20)NDC 82293-031-21Available to Order
- 28 TABLET in 1 BOTTLE (82293-031-10)NDC 82293-031-10Available to Order
Request This Medication
*Expect a reply within 2 business hours with availability and pricing.
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request a quote
Request this medication.
Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.
- DSCSA-compliant pedigree on every order
- Cold-chain capable where applicable
- Same-day fulfillment available for urgent needs
Related in Oncology & Specialty
See all →Verzenio (Abemaciclib)
50 mg/1 · Tablet
Eli Lilly and Company
Available to Source
Verzenio (Abemaciclib)
200 mg/1 · Tablet
Eli Lilly and Company
Available to Source
Verzenio (Abemaciclib)
100 mg/1 · Tablet
Eli Lilly and Company
Available to Source
Verzenio (Abemaciclib)
150 mg/1 · Tablet
Eli Lilly and Company
Available to Source
